Search company, investor...

Total Raised

$30.1M

Investors Count

9

Investments

1

Funding, Valuation & Revenue

5 Fundings

Gene Logic has raised $30.1M over 5 rounds.

Gene Logic's latest funding round was a IPO for $24M on November 21, 1997.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/21/1997

IPO

$24M

$99M

0

FY undefined

1

7/15/1997

Series B

$99M

$99M

0

FY undefined

10

3/29/1996

Series A

$99M

$99M

0

FY undefined

10

9/27/1995

Seed

$99M

$99M

0

FY undefined

10

11/1/1994

Seed VC

$99M

$99M

0

FY undefined

10

Date

11/21/1997

7/15/1997

3/29/1996

9/27/1995

11/1/1994

Round

IPO

Series B

Series A

Seed

Seed VC

Amount

$24M

$99M

$99M

$99M

$99M

Investors

Valuation

$99M

$99M

$99M

$99M

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

10

10

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Gene Logic Investors

9 Investors

Gene Logic has 9 investors. Granite Ventures invested in Gene Logic's Series B funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

7/15/1997

7/15/1997

1
Series B

Venture Capital

California

00/00/0000

00/00/0000

Biotechvest

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Forward Ventures

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Weiss, Peck & Greer Ventu

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Oxford Bioscience Partners

Subscribe to see more

Venture Capital

Massachusetts

First funding

7/15/1997

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

7/15/1997

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Biotechvest

Forward Ventures

Weiss, Peck & Greer Ventu

Oxford Bioscience Partners

Rounds

1
Series B

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Type

Venture Capital

Venture Capital

Venture Capital

Venture Capital

Location

California

California

California

Massachusetts

Gene Logic Investments

1 Investments

Gene Logic has made 1 investments. Their latest investment was in Metabometrix as part of their Seed on March 3, 2001.

CBI Logo

Gene Logic Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/1/2001

Seed

Metabometrix

$1.81M

Yes

1

Date

3/1/2001

Round

Seed

Company

Metabometrix

Amount

$1.81M

New?

Yes

Co-Investors

Sources

1

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.